Hair Mark 4

What Happened

• Mark Hair, Chief Financial Officer of Treace Medical Concepts, Inc. (TMCI), received a grant of 100,000 performance stock units (PSUs) on April 1, 2026. The reported acquisition price is $0.00, so there was no cash outlay. The PSUs were earned upon the Compensation Committee’s certification of a performance goal and will convert to shares upon vesting.

Key Details

• Transaction date: 2026-04-01 (reported on Form 4 filed 2026-04-03).
• Grant: 100,000 PSUs at $0.00 (no immediate cash value recorded at grant).
• Vesting schedule (per footnote): PSUs convert 1-for-1 to common shares; 25% vest on April 15, 2026 and 25% vest on each February 15 of 2027, 2028 and 2029, subject to continued service.
• Footnote F2: Indicates inclusion of 811,691 restricted stock units in reported holdings.
• Shares owned after transaction: not specified in the provided data; footnote F2 suggests significant outstanding RSU holdings.
• Filing timeliness: Form filed Apr 3, 2026 following the Apr 1 grant; no indication in the provided data that the filing was late.

Context

• These PSUs are a performance-based equity award, not an open-market purchase or sale. They become actual shares only if performance and service conditions are met and on scheduled vesting dates, so they are not immediately liquid.
• For retail investors, grants like this are routine executive compensation tied to performance goals; they are informative about incentive alignment but do not by themselves indicate the insider is buying or selling shares.